Literature DB >> 14715447

The vitamin-E analog trolox and the NMDA antagonist MK-801 protect pyramidal neurons in hippocampal slice cultures from IL-1beta-induced neurodegeneration.

Ann-Cathrin Radesäter1, Sara Johansson, Caroline Oberg, Johan Luthman.   

Abstract

The neurotoxic effect of the pro-inflammatory cytokine interleukin (IL)-1beta was studied in monolayer cultures, obtained using roller-drum incubation of hippocampal slices from neonatal Sprague Dawley rats. Following exposure to recombinant rat IL-1beta for four days, a concentration dependent loss was observed in the number of NMDAR1 receptor subunit immunoreactive pyramidal neurons in the cultures, reaching significance at 10 ng/ml rIL-1beta. Also incubation with recombinant mouse IL-1beta caused a loss of pyramidal neurons, with a significant effect at a concentration of 30 pg/ml. The vitamin E analog trolox (30 microM) was found to exert a protective effect against the rIL-1beta induced neuronal degeneration. A neuroprotective action against rIL-1beta was also found after co-incubation with the NMDA antagonist dizocilpine (MK-801; 30 microM), while no protection was found with the GABAA mimetic clomethiazole. Hence, the pro-inflammatory cytokine IL-1beta is neurotoxic to hippocampal pyramidal neurons when studied in an in vitro system with advanced phenotypic characteristics. The neuroprotective effects exerted by trolox and MK-801 suggest that free radicals and NMDA receptor-mediated processes are involved in IL-1beta -induced neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14715447     DOI: 10.1007/bf03033173

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  49 in total

1.  Visualization and characterization of interleukin 1 receptors in brain.

Authors:  W L Farrar; P L Kilian; M R Ruff; J M Hill; C B Pert
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

Review 2.  The role of cytokines in the neuropathology of stroke and neurotrauma.

Authors:  G Z Feuerstein; X Wang; F C Barone
Journal:  Neuroimmunomodulation       Date:  1998 May-Aug       Impact factor: 2.492

3.  Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation.

Authors:  J G Sheng; R A Jones; X Q Zhou; J M McGinness; L J Van Eldik; R E Mrak; W S Griffin
Journal:  Neurochem Int       Date:  2001 Nov-Dec       Impact factor: 3.921

Review 4.  Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression.

Authors:  W S Griffin; J G Sheng; M C Royston; S M Gentleman; J E McKenzie; D I Graham; G W Roberts; R E Mrak
Journal:  Brain Pathol       Date:  1998-01       Impact factor: 6.508

5.  Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain.

Authors:  M Minami; Y Kuraishi; M Satoh
Journal:  Biochem Biophys Res Commun       Date:  1991-04-30       Impact factor: 3.575

6.  Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain.

Authors:  B Brugg; Y L Dubreuil; G Huber; E E Wollman; N Delhaye-Bouchaud; J Mariani
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

7.  Methamphetamine-induced expression of interleukin-1 beta mRNA in the rat hypothalamus.

Authors:  T Yamaguchi; Y Kuraishi; M Minami; S Nakai; Y Hirai; M Satoh
Journal:  Neurosci Lett       Date:  1991-07-08       Impact factor: 3.046

8.  Electrophysiological actions of gamma-aminobutyric acid and clomethiazole on recombinant GABA(A) receptors.

Authors:  Rachael M Nelson; A Richard Green; Atticus H Hainsworth
Journal:  Eur J Pharmacol       Date:  2002-10-11       Impact factor: 4.432

9.  Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease.

Authors:  J G Sheng; W S Griffin; M C Royston; R E Mrak
Journal:  Neuropathol Appl Neurobiol       Date:  1998-08       Impact factor: 8.090

10.  Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures.

Authors:  A Vezzani; M Conti; A De Luigi; T Ravizza; D Moneta; F Marchesi; M G De Simoni
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

View more
  8 in total

1.  Salmonella lipopolysaccharide (LPS) mediated neurodegeneration in hippocampal slice cultures.

Authors:  Sara Johansson; Svante Bohman; Ann-Cathrin Radesäter; Caroline Oberg; Johan Luthman
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

Review 2.  Clinical physiology and mechanism of dizocilpine (MK-801): electron transfer, radicals, redox metabolites and bioactivity.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Oxid Med Cell Longev       Date:  2010 Jan-Feb       Impact factor: 6.543

3.  Ketamine and the myenteric plexus in intestinal ischemia/reperfusion injury.

Authors:  Francisco Javier Guzmán-de la Garza; Carlos Rodrigo Cámara-Lemarroy; Raquel Guadalupe Ballesteros-Elizondo; Gabriela Alarcón-Galván; Paula Cordero-Pérez; Nancy Esthela Fernández-Garza
Journal:  Dig Dis Sci       Date:  2009-09-16       Impact factor: 3.199

4.  Silica nanoparticles induce neurodegeneration-like changes in behavior, neuropathology, and affect synapse through MAPK activation.

Authors:  Ran You; Yuen-Shan Ho; Clara Hiu-Ling Hung; Yan Liu; Chun-Xia Huang; Hei-Nga Chan; See-Lok Ho; Sheung-Yeung Lui; Hung-Wing Li; Raymond Chuen-Chung Chang
Journal:  Part Fibre Toxicol       Date:  2018-07-03       Impact factor: 9.400

5.  The Impact of the Combined Administration of 1MeTIQ and MK-801 on Cell Viability, Oxidative Stress Markers, and Glutamate Release in the Rat Hippocampus.

Authors:  Agnieszka Wąsik; Magdalena Białoń; Danuta Jantas; Marcelina Żarnowska
Journal:  Neurotox Res       Date:  2021-10-19       Impact factor: 3.911

Review 6.  The Potential of Small Molecules to Modulate the Mitochondria-Endoplasmic Reticulum Interplay in Alzheimer's Disease.

Authors:  Giacomo Dentoni; Laura Castro-Aldrete; Luana Naia; Maria Ankarcrona
Journal:  Front Cell Dev Biol       Date:  2022-08-26

Review 7.  Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review.

Authors:  Richard M Kostrzewa; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

8.  Tacrine, Trolox and Tryptoline as Lead Compounds for the Design and Synthesis of Multi-target Agents for Alzheimer's Disease Therapy.

Authors:  Gerard A K Teponnou; Jacques Joubert; Sarel F Malan
Journal:  Open Med Chem J       Date:  2017-01-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.